88 related articles for article (PubMed ID: 25450645)
1. The role of circulating adiponectin in prostate cancer: a meta-analysis.
Liao Q; Long C; Deng Z; Bi X; Hu J
Int J Biol Markers; 2015 Feb; 30(1):e22-31. PubMed ID: 25450645
[TBL] [Abstract][Full Text] [Related]
2. Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies.
Wei T; Ye P; Peng X; Wu LL; Yu GY
Oncotarget; 2016 Jul; 7(30):48671-48691. PubMed ID: 27119501
[TBL] [Abstract][Full Text] [Related]
3. Circulating adiponectin levels and the risk of breast cancer: a meta-analysis.
Ye J; Jia J; Dong S; Zhang C; Yu S; Li L; Mao C; Wang D; Chen J; Yuan G
Eur J Cancer Prev; 2014 May; 23(3):158-65. PubMed ID: 23929213
[TBL] [Abstract][Full Text] [Related]
4. Circulating adiponectin and risk of endometrial cancer.
Zheng Q; Wu H; Cao J
PLoS One; 2015; 10(6):e0129824. PubMed ID: 26030130
[TBL] [Abstract][Full Text] [Related]
5. No association of plasma levels of adiponectin and c-peptide with risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Stevens VL; Jacobs EJ; Sun J; Gapstur SM
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):890-2. PubMed ID: 24585409
[TBL] [Abstract][Full Text] [Related]
6. Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis.
Burton AJ; Gilbert R; Tilling K; Langdon R; Donovan JL; Holly JMP; Martin RM
Sci Rep; 2021 Jan; 11(1):320. PubMed ID: 33431998
[TBL] [Abstract][Full Text] [Related]
7. Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: Evidence from a meta-analysis of epidemiologic studies.
Gong TT; Wu QJ; Wang YL; Ma XX
Int J Cancer; 2015 Oct; 137(8):1967-78. PubMed ID: 25899043
[TBL] [Abstract][Full Text] [Related]
8. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
9. The role of adiponectin in breast cancer: a meta-analysis.
Liu LY; Wang M; Ma ZB; Yu LX; Zhang Q; Gao DZ; Wang F; Yu ZG
PLoS One; 2013; 8(8):e73183. PubMed ID: 23991180
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin levels in patients with psoriasis: a meta-analysis.
Zhu KJ; Shi G; Zhang C; Li M; Zhu CY; Fan YM
J Dermatol; 2013 Jun; 40(6):438-42. PubMed ID: 23731474
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma.
Xu XT; Xu Q; Tong JL; Zhu MM; Huang ML; Ran ZH; Xiao SD
J Dig Dis; 2011 Aug; 12(4):234-44. PubMed ID: 21791018
[TBL] [Abstract][Full Text] [Related]
12. Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis.
Macis D; Guerrieri-Gonzaga A; Gandini S
Int J Epidemiol; 2014 Aug; 43(4):1226-36. PubMed ID: 24737805
[TBL] [Abstract][Full Text] [Related]
13. Associations of coffee consumption with circulating level of adiponectin and leptin. A meta-analysis of observational studies.
Zhang Y; Zhang DZ
Int J Food Sci Nutr; 2018 Dec; 69(8):1003-1012. PubMed ID: 29513118
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies.
YuPeng L; YuXue Z; PengFei L; Cheng C; YaShuang Z; DaPeng L; Chen D
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1086-93. PubMed ID: 25953767
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis.
An W; Bai Y; Deng SX; Gao J; Ben QW; Cai QC; Zhang HG; Li ZS
Eur J Cancer Prev; 2012 Mar; 21(2):126-33. PubMed ID: 21960184
[TBL] [Abstract][Full Text] [Related]
16. In prostate cancer, low adiponectin levels are not associated with insulin resistance.
Michalakis K; Venihaki M; Mantzoros C; Vazaiou A; Ilias I; Gryparis A; Margioris AN
Eur J Clin Invest; 2015 Jun; 45(6):572-8. PubMed ID: 25833038
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin is associated with poor prognosis in carcinoma patients: evidence from a meta-analysis.
Ye J; Liang Z; Liang Q; Zhang J; Mao S; Liang R
Lipids Health Dis; 2015 Nov; 14():154. PubMed ID: 26612049
[TBL] [Abstract][Full Text] [Related]
18. Serum adiponectin and leptin levels are useful markers for prostate cancer screening after adjustments for age, obesity-related factors, and prostate volume.
Nishimura K; Soda T; Nakazawa S; Yamanaka K; Hirai T; Kishikawa H; Ichikawa Y
Minerva Urol Nefrol; 2012 Sep; 64(3):199-208. PubMed ID: 22971685
[TBL] [Abstract][Full Text] [Related]
19. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study.
Michalakis K; Williams CJ; Mitsiades N; Blakeman J; Balafouta-Tselenis S; Giannopoulos A; Mantzoros CS
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):308-13. PubMed ID: 17301264
[TBL] [Abstract][Full Text] [Related]
20. Association between adiponectin concentrations and diabetic retinopathy in patients with type 2 diabetes: a meta analysis.
Fan X; Wu Q; Li Y; Hao Y; Ning N; Kang Z; Cui Y; Liu R; Han L
Chin Med J (Engl); 2014; 127(4):765-71. PubMed ID: 24534238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
